Psychedelic biotech MAPS PBC rebrands to Lykos following FDA filing, scores $100M financing
MAPS PBC [Public Benefit Corporation) has rebranded to Lykos Therapeutics [a for-profit public benefit corporation (“PBC”)], (“Lykos”), the greek word for wolf. MAPS PBC spun out of its parent organization MAPS (Multidisciplinary Association for Psychedelic Studies)… clinical development effort of MDMA-assisted therapy [midomafetamine capsules used in combination with psychological intervention], which includes talk therapy, and…
Recent Comments